Nightingale Health

Nightingale Health is a blood analysis company enabling preventive healthcare.


We are liberating access to molecular level health data to predict and prevent chronic diseases - the world’s biggest health problem.


Problem

Why better health data is needed

Chronic diseases are on the rise globally. The annual costs of cardiovascular disease and diabetes account to over 1.3 trillion dollars worldwide, 0.6% of the world’s GDP. Treating chronic diseases better is not sufficient. To solve the global burden, we need to prevent diseases and keep people healthy.

Solution

Towards better prediction

Detailed molecular level data is crucial for the prediction and prevention of metabolic diseases that develop throughout a lifetime. However, due to the high-cost of current technologies, extensive molecular data has not been routinely available. We have developed a blood analysis platform that changes this.

Nightingale’s approach

Nightingale’s blood analysis platform brings detailed molecular data available with low-cost. Whereas the current clinical practice routinely captures five biomarkers to diagnose and treat heart disease and diabetes, Nightingale’s platform provides over 220 biomarkers from a single blood sample with the same price level.

home.approach.alt

Used in world-class science

Nightingale’s blood analysis platform is already widely used in research to advance the molecular understanding of chronic disease development and improve prediction of disease onset. We cooperate with the most highly-esteemed medical institutions and the platform has been used in over 100 peer-reviewed publications.

Enabling preventive healthcare

Our blood analysis platform has been designed for routine healthcare settings and scientific evidence is continuously accumulating to demonstrate clinical benefits. The more our technology is utilized and data is created, the stronger is its predictive power. Accurate prediction is the key to prevent disease before onset – and empowering proactive healthcare.

Latest news

Stay in the know!
Subscribe to our newsletter